Goldman Sachs lifts Carl Zeiss Meditec voting rights to 5.02% from 4.86%
Bitget2026/09/25 05:50- Goldman Sachs lifted its total voting rights stake in Carl Zeiss Meditec to 5.02% from 4.86%.
- Voting rights attached to shares rose to 0.56% from 0.51%.
- Voting rights through instruments increased to 4.46% from 4.35%.
- Threshold was crossed on Sep. 18, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote